Target intelligence / Profile preview

Neuromelanin-iron complex (NM-Fe)

Target
NM-Fe
Molecular classification
Other, Biopolymer, Pigment-metal complex
01

Overview

The neuromelanin-iron complex is a specialized biopolymer found within the catecholaminergic neurons of the human brain, most notably in the substantia nigra pars compacta and the locus coeruleus (Zecca et al., 2003, PubMed: 12542511). It is formed through the oxidative polymerization of dopamine or norepinephrine and serves as a high-capacity storage site for transition metals, particularly iron (Fe3+) (Zucca et al., 2017, PubMed: 28130336). Under physiological conditions, this complex acts as a neuroprotective agent by sequestering potentially toxic free iron and reactive oxygen species. In the context of Parkinson's disease, the progressive loss of these neuromelanin-rich neurons leads to the release of sequestered iron and pro-inflammatory components, contributing to chronic neurodegeneration (Sulzer et al., 2018, PubMed: 29351850). Consequently, the neuromelanin-iron complex is utilized as a critical biomarker in neuromelanin-sensitive MRI for early diagnosis and is a target for neuroprotective therapies, such as iron chelators like Deferiprone, designed to mitigate oxidative damage (Devos et al., 2014, PubMed: 24457109).

Other names
NeuromelaninNMMelanin-iron complexNeuromelanin-bound ironSubstantia nigra pigmentMelanin/neuromelanin- and iron-rich components
02

Mechanism of action

Iron chelation to reduce oxidative stress; modulation of dopamine metabolism to influence pigment synthesis; sequestration of toxic metabolites.

03

Biological functions

OtherMetal sequestrationNeuroprotectionOxidative stress modulationWaste product sequestration
04

Disease associations

Neurodegenerative diseaseParkinson's diseaseAlzheimer's disease
05

Safety considerations

Potential for iron dyshomeostasisRelease of toxic metals upon neuronal lysisPro-oxidant transition if iron-binding capacity is exceeded
06

Interacting drugs

Deferiprone

3 more in the full profile.

07

Biomarkers

Neuromelanin-sensitive MRI (NM-MRI) signal intensitySubstantia nigra depigmentationIron-sensitive MRI (R2*)

Beyond the preview

Go deeper on Neuromelanin-iron complex (NM-Fe).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuromelanin-iron complex (NM-Fe).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call